scispace - formally typeset
Open AccessJournal ArticleDOI

Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorization

Reads0
Chats0
TLDR
It is demonstrated that pathway-response associations can be learned by the proposed model for the well-known EGFR and MEK inhibitors, opening up the opportunity for elucidating drug action mechanisms.
Abstract
Motivation A key goal of computational personalized medicine is to systematically utilize genomic and other molecular features of samples to predict drug responses for a previously unseen sample. Such predictions are valuable for developing hypotheses for selecting therapies tailored for individual patients. This is especially valuable in oncology, where molecular and genetic heterogeneity of the cells has a major impact on the response. However, the prediction task is extremely challenging, raising the need for methods that can effectively model and predict drug responses. Results In this study, we propose a novel formulation of multi-task matrix factorization that allows selective data integration for predicting drug responses. To solve the modeling task, we extend the state-of-the-art kernelized Bayesian matrix factorization (KBMF) method with component-wise multiple kernel learning. In addition, our approach exploits the known pathway information in a novel and biologically meaningful fashion to learn the drug response associations. Our method quantitatively outperforms the state of the art on predicting drug responses in two publicly available cancer datasets as well as on a synthetic dataset. In addition, we validated our model predictions with lab experiments using an in-house cancer cell line panel. We finally show the practical applicability of the proposed method by utilizing prior knowledge to infer pathway-drug response associations, opening up the opportunity for elucidating drug action mechanisms. We demonstrate that pathway-response associations can be learned by the proposed model for the well-known EGFR and MEK inhibitors. Availability and implementation The source code implementing the method is available at http://research.cs.aalto.fi/pml/software/cwkbmf/ Contacts muhammad.ammad-ud-din@aalto.fi or samuel.kaski@aalto.fi Supplementary information Supplementary data are available at Bioinformatics online.

read more

Citations
More filters
Journal ArticleDOI

The rise of deep learning in drug discovery.

TL;DR: The first wave of applications of deep learning in pharmaceutical research has emerged in recent years, and its utility has gone beyond bioactivity predictions and has shown promise in addressing diverse problems in drug discovery.
Journal ArticleDOI

Machine learning and feature selection for drug response prediction in precision oncology applications

TL;DR: The state-of-the-art machine learning methods for anti-cancer drug response modeling and prediction are described and a perspective on further opportunities to make better use of high-dimensional multi-omics profiles are given.
Journal ArticleDOI

Predicting Cancer Drug Response using a Recommender System

TL;DR: This work proposes a method based on ideas from ‘recommender systems’ (CaDRReS) that predicts cancer drug responses for unseen cell‐lines/patients based on learning projections for drugs and cell‐ lines into a latent ‘pharmacogenomic’ space.
Journal ArticleDOI

Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network

TL;DR: This approach is able to predict the drug effects on cancer cell lines with high accuracy, and its performance remains stable with less but high-quality data, and with fewer features for the cancer cell Lines.
References
More filters
Journal ArticleDOI

Controlling the false discovery rate: a practical and powerful approach to multiple testing

TL;DR: In this paper, a different approach to problems of multiple significance testing is presented, which calls for controlling the expected proportion of falsely rejected hypotheses -the false discovery rate, which is equivalent to the FWER when all hypotheses are true but is smaller otherwise.
Journal ArticleDOI

Regularization and variable selection via the elastic net

TL;DR: It is shown that the elastic net often outperforms the lasso, while enjoying a similar sparsity of representation, and an algorithm called LARS‐EN is proposed for computing elastic net regularization paths efficiently, much like algorithm LARS does for the lamba.
Journal ArticleDOI

Regularization Paths for Generalized Linear Models via Coordinate Descent

TL;DR: In comparative timings, the new algorithms are considerably faster than competing methods and can handle large problems and can also deal efficiently with sparse features.
Journal ArticleDOI

The control of the false discovery rate in multiple testing under dependency

TL;DR: In this paper, it was shown that a simple FDR controlling procedure for independent test statistics can also control the false discovery rate when test statistics have positive regression dependency on each of the test statistics corresponding to the true null hypotheses.
Journal ArticleDOI

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

TL;DR: The results indicate that large, annotated cell-line collections may help to enable preclinical stratification schemata for anticancer agents and the generation of genetic predictions of drug response in the preclinical setting and their incorporation into cancer clinical trial design could speed the emergence of ‘personalized’ therapeutic regimens.
Related Papers (5)